(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Hostess Brands, Verb Technology Company, and Target Hospitality Corp..

The three biggest losers today are VerifyMe, WW International , and Neuronetics.

Winners today

1. Hostess Brands (TWNKW) – 41.59%

Hostess Brands, Inc., a packaged food company, develops, manufactures, markets, sells, and distributes fresh sweet baked goods in the United States. It primarily offer a range of snack cakes, donuts, sweet rolls, breakfast pastries, snack pies, and related products. The company operates in two segments, Sweet Baked Goods and In-Store Bakery. The Sweet Baked Goods segment offers fresh and frozen sweet baked goods and bread products under the Hostess, Dolly Madison, Cloverhill, and Big Texas brands, as well as store branded products. The In-Store Bakery segment primarily provides Superior on Main branded eclairs, madeleines, brownies, and iced cookies in the bakery section of grocery and club stores. The company was formerly known as Gores Holdings, Inc. and changed its name to Hostess Brands, Inc. in November 2016. Hostess Brands, Inc. was founded in 1919 and is based in Lenexa, Kansas.

NASDAQ ended the session with Hostess Brands jumping 41.59% to $3.20 on Wednesday while NASDAQ jumped 0.4% to $11,576.00.

PE Ratio

Hostess Brands has a trailing twelve months price to earnings ratio of 5.15. Meaning, the purchaser of the share is investing $5.15 for every dollar of annual earnings.

More news about Hostess Brands.

2. Verb Technology Company (VERBW) – 15.31%

NASDAQ ended the session with Verb Technology Company jumping 15.31% to $0.04 on Wednesday while NASDAQ jumped 0.4% to $11,576.00.

Yearly Top and Bottom Value

Verb Technology Company’s stock is valued at $0.04 at 16:32 EST, higher than its 52-week high of $0.04.

More news about Verb Technology Company.

3. Target Hospitality Corp. (THWWW) – 8.44%

NASDAQ ended the session with Target Hospitality Corp. rising 8.44% to $5.27 on Wednesday, after five consecutive sessions in a row of losses. NASDAQ jumped 0.4% to $11,576.00, after two sequential sessions in a row of losses, on what was a somewhat up trend trading session today.

Yearly Top and Bottom Value

Target Hospitality Corp.’s stock is valued at $5.27 at 16:32 EST, below its 52-week low of $4.96.

More news about Target Hospitality Corp..

4. Stable Road Acquisition Corp. (SRACU) – 8.35%

NASDAQ ended the session with Stable Road Acquisition Corp. rising 8.35% to $12.20 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ rose 0.4% to $11,576.00, after two consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for Stable Road Acquisition Corp. is 1893 which is 4.58% above its average volume of 1810.

Yearly Top and Bottom Value

Stable Road Acquisition Corp.’s stock is valued at $12.20 at 16:32 EST, way below its 52-week high of $35.00 and way above its 52-week low of $9.78.

Moving Average

Stable Road Acquisition Corp.’s value is higher than its 50-day moving average of $12.08 and way under its 200-day moving average of $15.74.

More news about Stable Road Acquisition Corp..

5. XP (XP) – 8.17%

XP Inc. provides financial products and services in Brazil. It offers securities brokerage, private pension plans, commercial, and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth customers and institutional clients. The company also offers Xpeed, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals on topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, private equity, structured products, credit cards, loan operations, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in São Paulo, Brazil.

NASDAQ ended the session with XP jumping 8.17% to $12.91 on Wednesday while NASDAQ jumped 0.4% to $11,576.00.

Earnings Per Share

As for profitability, XP has a trailing twelve months EPS of $0.99.

PE Ratio

XP has a trailing twelve months price to earnings ratio of 13.1. Meaning, the purchaser of the share is investing $13.1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.52%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 13.12B for the twelve trailing months.

Yearly Top and Bottom Value

XP’s stock is valued at $12.91 at 16:32 EST, way under its 52-week high of $33.83 and above its 52-week low of $12.40.

More news about XP.

6. Scholar Rock Holding Corporation (SRRK) – 6.55%

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Scholar Rock Holding Corporation rising 6.55% to $9.92 on Wednesday, after four consecutive sessions in a row of gains. NASDAQ jumped 0.4% to $11,576.00, after two consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Scholar Rock Holding Corporation has a trailing twelve months EPS of $-2.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -54.59%.

Moving Average

Scholar Rock Holding Corporation’s worth is under its 50-day moving average of $10.29 and way above its 200-day moving average of $8.28.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 41.2% and a drop 181% for the next.

Volume

Today’s last reported volume for Scholar Rock Holding Corporation is 395784 which is 51.21% above its average volume of 261730.

More news about Scholar Rock Holding Corporation.

7. Xcel Brands (XELB) – 6.23%

Xcel Brands, Inc., together with its subsidiaries, operates as a media and consumer products company in the United States. The company designs, produces, licenses, markets, and sells branded apparel, footwear, accessories, jewelry, home goods, and other consumer products; and acquires consumer lifestyle brands, including the Isaac Mizrahi, the Judith Ripka, the H Halston, the Halston Heritage, and the C Wonder brands. It licenses its brands to third parties; and provides design, production, and marketing services for promotion and distribution through a ubiquitous-channel retail sales strategy, including distribution through interactive television, the Internet, and traditional brick-and-mortar retail channels. The company also offers social media marketing and other marketing, and public relations support for its brands. In addition, it markets the Mizrahi brands through isaacmizrahi.com; the Halston Brand through halston.com; the Judith Ripka Fine Jewelry brand through judithripka.com; and the C Wonder brands through cwonder.com. Xcel Brands, Inc. is headquartered in New York, New York.

NASDAQ ended the session with Xcel Brands rising 6.23% to $0.81 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.4% to $11,576.00, after two consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Xcel Brands has a trailing twelve months EPS of $-0.26.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.83%.

Moving Average

Xcel Brands’s value is above its 50-day moving average of $0.79 and way below its 200-day moving average of $1.01.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Xcel Brands’s EBITDA is -3.75.

Yearly Top and Bottom Value

Xcel Brands’s stock is valued at $0.81 at 16:32 EST, way below its 52-week high of $1.99 and way higher than its 52-week low of $0.67.

More news about Xcel Brands.

8. Voyager Therapeutics (VYGR) – 5.99%

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia; and alpha-synuclein program for synucleinopathies, Parkinson's disease, Lewy Body Dementia, and multiple system atrophy. The company has strategic collaboration agreements with the University of Massachusetts; and ClearPoint Neuro, Inc., as well as collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to support the development of its gene therapy programs. It also has a collaboration and license agreement with Neurocrine Biosciences, Inc. for the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Voyager Therapeutics rising 5.99% to $7.78 on Wednesday, following the last session’s downward trend. NASDAQ rose 0.4% to $11,576.00, after two consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Voyager Therapeutics has a trailing twelve months EPS of $-0.41.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.08%.

Previous days news about Voyager Therapeutics

• Voyager therapeutics (vygr) reports Q4 loss, misses revenue estimates. According to Zacks on Tuesday, 7 March, "While Voyager Therapeutics has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Voyager Therapeutics.

9. ON Semiconductor (ON) – 5.74%

ON Semiconductor Corporation provides intelligent sensing and power solutions in the United States and internationally. The company operates through three segments: Power Solutions Group, Advanced Solutions Group, and Intelligent Sensing Group. Its intelligent power technologies enable the electrification of the automotive industry that allows for lighter and longer-range electric vehicles, empowers fast-charging systems, and propels sustainable energy for the solar strings, industrial power, and storage systems. The company offers analog, discrete, module, and integrated semiconductor products that perform multiple application functions, includes power switching and conversion, signal conditioning, circuit protection, signal amplification, and voltage regulation functions. The company also designs and develops analog, mixed-signal, advanced logic, application specific standard product and ASICs, radio frequency, and integrated power solutions for end-users in end-markets, as well as provides foundry and design services for government customers. In addition, it develops complementary metal oxide semiconductor image sensors, image signal processors, and single photon detectors, include silicon photomultipliers and single photon avalanche diode arrays, as well as actuator drivers for autofocus and image stabilization for a broad base of end-users in various end-markets. ON Semiconductor Corporation was incorporated in 1992 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with ON Semiconductor jumping 5.74% to $83.21 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.4% to $11,576.00, after two sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, ON Semiconductor has a trailing twelve months EPS of $0.79.

PE Ratio

ON Semiconductor has a trailing twelve months price to earnings ratio of 105.87. Meaning, the purchaser of the share is investing $105.87 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.22%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 10.7% and a negative 20.9%, respectively.

More news about ON Semiconductor.

10. Geo Group (GEO) – 5.59%

The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO's diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO's worldwide operations include the ownership and/or delivery of support services for 102 facilities totaling approximately 82,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees.

NYSE ended the session with Geo Group jumping 5.59% to $8.81 on Wednesday while NYSE jumped 0.02% to $15,441.38.

Earnings Per Share

As for profitability, Geo Group has a trailing twelve months EPS of $0.94.

PE Ratio

Geo Group has a trailing twelve months price to earnings ratio of 9.37. Meaning, the purchaser of the share is investing $9.37 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.55%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 31.6% and positive 11.5% for the next.

More news about Geo Group.

Losers Today

1. VerifyMe (VRMEW) – -25.72%

NASDAQ ended the session with VerifyMe sliding 25.72% to $0.19 on Wednesday while NASDAQ jumped 0.4% to $11,576.00.

Yearly Top and Bottom Value

VerifyMe’s stock is valued at $0.19 at 16:32 EST, above its 52-week high of $0.19.

More news about VerifyMe.

2. WW International (WW) – -23.35%

WW International, Inc. provides weight management products and services worldwide. The company operates in four segments: North America, Continental Europe, United Kingdom, and Other. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program via its Web-based and mobile app products, including personal coaching and digital products; and allows members to inspire and support each other by sharing their experiences with other people on weight management and wellness journeys. In addition, it offers various consumer products, including bars, snacks, cookbooks, kitchen tools, and other products. Further, the company licenses its trademarks and other intellectual property in food, beverages, and other consumer products and services. It offers products through its e-commerce platform, workshops, magazine subscriptions, retail partners, publishing, and third-party advertising in publications; and through Websites and sales from the By Mail product. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.

NASDAQ ended the session with WW International dropping 23.35% to $5.31 on Wednesday while NASDAQ rose 0.4% to $11,576.00.

Earnings Per Share

As for profitability, WW International has a trailing twelve months EPS of $1.07.

PE Ratio

WW International has a trailing twelve months price to earnings ratio of 4.96. Meaning, the purchaser of the share is investing $4.96 for every dollar of annual earnings.

More news about WW International .

3. Neuronetics (STIM) – -19.19%

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

NASDAQ ended the session with Neuronetics sliding 19.19% to $4.21 on Wednesday while NASDAQ rose 0.4% to $11,576.00.

Earnings Per Share

As for profitability, Neuronetics has a trailing twelve months EPS of $-1.32.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.39%.

More news about Neuronetics.

4. Xeris Pharmaceuticals (XERS) – -12.09%

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. Its proprietary XeriSol and XeriJect formulation technology platforms allow for the subcutaneous and intramuscular delivery of highly-concentrated, ready-to-use formulations of peptides, small molecules, and proteins using commercially available syringes, auto-injectors, multi-dose pens, and infusion pumps. The company's lead product candidate is Gvoke HypoPen for the treatment of severe hypoglycemia, a potentially life-threatening condition in people with diabetes. Its product candidates also comprise ready-to-use glucagon that has completed Phase II clinical trials for the treatment of post-bariatric hypoglycemia, exercise-induced hypoglycemia in diabetes, bi-hormonal artificial pancreas closed-loop systems, congenital hyperinsulinism, and hypoglycemia-associated autonomic failure; and hypoglycemia associated with intermittent and chronic conditions. In addition, it develops ready-to-use diazepam formulation, which is in Phase Ib clinical trial for the treatment of Dravet syndrome and acute repetitive seizures in patients with epilepsy; and Pramlintide-Insulin co-formulation that is Phase II clinical trials for treating type 1 and 2 diabetes. Xeris Pharmaceuticals, Inc. serves patients, caregivers, and health practitioners. The company was founded in 2005 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Xeris Pharmaceuticals sliding 12.09% to $1.34 on Wednesday while NASDAQ rose 0.4% to $11,576.00.

Earnings Per Share

As for profitability, Xeris Pharmaceuticals has a trailing twelve months EPS of $-1.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -504.08%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 168.8%, now sitting on 98.53M for the twelve trailing months.

Yearly Top and Bottom Value

Xeris Pharmaceuticals’s stock is valued at $1.34 at 16:32 EST, way under its 52-week high of $2.95 and way above its 52-week low of $0.97.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 61.9% and 40%, respectively.

More news about Xeris Pharmaceuticals.

5. Veritone (VERI) – -11.84%

Veritone, Inc. provides artificial intelligence (AI) and computing solutions in the United States and the United Kingdom. It develops and operates aiWARE platform, an AI operating system that integrates and orchestrates a range of cognitive engines to reveal multivariate insights from structured and unstructured data, as well as to conduct cognitive workflows based on these insights. The company also provides media advertising agency services, including media planning and strategy, media buying and placement, campaign messaging, clearance verification and attribution, and custom analytics directly to advertisers through outbound sales networking, and client and partner referrals, as well as indirectly through advertising agencies or marketing consultants. It serves media and entertainment, legal and compliance, and government markets The company was formerly known as Veritone Delaware, Inc. and changed its name to Veritone, Inc. in July 2014. Veritone, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.

NASDAQ ended the session with Veritone dropping 11.84% to $6.85 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.4% to $11,576.00, after two successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Veritone has a trailing twelve months EPS of $-0.62.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.4%.

Moving Average

Veritone’s worth is under its 50-day moving average of $7.22 and below its 200-day moving average of $6.94.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Veritone’s EBITDA is 1.49.

Revenue Growth

Year-on-year quarterly revenue growth declined by 20.4%, now sitting on 149.73M for the twelve trailing months.

Volume

Today’s last reported volume for Veritone is 1013360 which is 26.49% above its average volume of 801118.

More news about Veritone.

6. Yunji (YJ) – -11.81%

Yunji Inc. operates a social e-commerce platform in the People's Republic of China. It offers a range of product categories that cater various daily needs of users and their households, including beauty and personal care, household goods, cloths, food and fresh produce, computer and electronics, apparel, bags and cases, baby and maternity products, and home appliances. The company was founded in 2015 and is headquartered in Hangzhou, the People's Republic of China.

NASDAQ ended the session with Yunji falling 11.81% to $0.41 on Wednesday while NASDAQ jumped 0.4% to $11,576.00.

Earnings Per Share

As for profitability, Yunji has a trailing twelve months EPS of $-0.108.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.97%.

Volume

Today’s last reported volume for Yunji is 307836 which is 6.34% above its average volume of 289474.

More news about Yunji.

7. Full House Resorts (FLL) – -11.08%

Full House Resorts, Inc. owns, develops, invests in, operates, manages, and leases casinos, and related hospitality and entertainment facilities in the United States. The company owns and operates the Silver Slipper Casino and Hotel in Hancock County, Mississippi, which has 757 slot machines and 24 table games, a surface parking lot, and a 129 hotel rooms; an on-site sportsbook, a fine-dining restaurant, a buffet, and a quick-service restaurant, as well as an oyster bar, a casino bar, and a beachfront bar; and 37-space beachfront RV park. It also owns and operates the Bronco Billy's Casino and Hotel in Cripple Creek, Colorado that has gaming space and 14 hotel rooms, as well as a steakhouse and a casual dining outlet. In addition, the company owns and operates the Rising Star Casino Resort in Rising Sun, Indiana, which has 642 slot machines and 16 table games; a land-based pavilion with approximately 31,500 square feet of meeting and convention space; a contiguous 190-guest-room hotel and an adjacent leased 104-guest-room hotel; a 56-space RV park; surface parking; an 18-hole golf course on approximately 230 acres; and four dining outlets. Further, it owns and operates the Stockman's Casino that is located in Fallon, Nevada, which has 186 slot machines, a bar, a fine-dining restaurant, and a coffee shop; and the Grand Lodge Casino that has 269 slot machines and 9 table games, which is integrated into the Hyatt Regency Lake Tahoe Resort, Spa and Casino in Incline Village, Nevada. Full House Resorts, Inc. was incorporated in 1987 and is headquartered in Las Vegas, Nevada.

NASDAQ ended the session with Full House Resorts dropping 11.08% to $8.83 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.4% to $11,576.00, after two consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

PE Ratio

Full House Resorts has a trailing twelve months price to earnings ratio of 1766. Meaning, the purchaser of the share is investing $1766 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.6%.

Moving Average

Full House Resorts’s value is above its 50-day moving average of $8.81 and way above its 200-day moving average of $7.18.

Volatility

Full House Resorts’s last week, last month’s, and last quarter’s current intraday variation average was 0.41%, 0.09%, and 2.14%.

Full House Resorts’s highest amplitude of average volatility was 0.92% (last week), 1.92% (last month), and 2.14% (last quarter).

More news about Full House Resorts.

8. So-Young International (SY) – -9.89%

So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the People's Republic of China and internationally. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment. As of December 31, 2020, it had approximately 6,900 medical aesthetic service providers and 4,200 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the People's Republic of China and internationally. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment. As of December 31, 2020, it had approximately 6,900 medical aesthetic service providers and 4,200 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.

NASDAQ ended the session with So-Young International sliding 9.89% to $2.55 on Wednesday, after two consecutive sessions in a row of losses. NASDAQ rose 0.4% to $11,576.00, after two successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, So-Young International has a trailing twelve months EPS of $-0.17.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.93%.

More news about So-Young International.

9. Windtree Therapeutics (WINT) – -9.24%

Windtree Therapeutics, Inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. Its four lead development programs include istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as in Phase 2a clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase 2b clinical trial to treat respiratory distress syndrome (RDS) in premature infants; lyophilized KL4 surfactant for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase 2b clinical trial for the treatment of genetically associated hypertension. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania.

NASDAQ ended the session with Windtree Therapeutics falling 9.24% to $5.50 on Wednesday while NASDAQ jumped 0.4% to $11,576.00.

Earnings Per Share

As for profitability, Windtree Therapeutics has a trailing twelve months EPS of $-72.8.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -126%.

Moving Average

Windtree Therapeutics’s value is way under its 50-day moving average of $8.49 and way under its 200-day moving average of $14.66.

Volume

Today’s last reported volume for Windtree Therapeutics is 53312 which is 48.81% below its average volume of 104163.

More news about Windtree Therapeutics.

10. Tattooed Chef (TTCF) – -7.44%

Tattooed Chef, Inc., a plant-based food company, produces and sells a portfolio of frozen foods. It supplies plant-based products to retailers in the United States. The company offers ready-to-cook bowls, zucchini spirals, riced cauliflower, acai and smoothie bowls, cauliflower crust pizza, and plant-based burgers. Its products are available in private label and Tattooed Chef brand name in the frozen food section of retail food stores. As of December 31, 2021, it operated approximately 14,000 retail outlets. Tattooed Chef, Inc. is headquartered in Paramount, California.

NASDAQ ended the session with Tattooed Chef sliding 7.44% to $1.12 on Wednesday, after two sequential sessions in a row of gains. NASDAQ rose 0.4% to $11,576.00, after two sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Tattooed Chef has a trailing twelve months EPS of $-0.069.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.72%.

More news about Tattooed Chef.

Stay up to date with our winners and losers daily report